Hassan, S.S., Mukhtar, E.J.H.A. and Madlum, K.N. 2022. Metabolic pathways inhibitors can affect the therapeutic efficiency of doxorubicin. International journal of health sciences. 6, S2 (May 2022), 9099–9108. DOI:https://doi.org/10.53730/ijhs.v6nS2.7375.